In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 73 for your search:
Drug:  leuprolide acetate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TRE1001, NCT01161563

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A-97-52014-181, 2011-004213-16, NCT01673984

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8494, MAOP-4384, NCCTG-INT-0036, NCOG-4P842J, NPCTG-2200, INT-0036

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: premenopausal
Sponsor:
Protocol IDs: MSHMC-1609, NCI-V87-0248

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 84
Sponsor:
Protocol IDs: MSHMC-1642, NCI-V87-0249

6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 40 to 85
Sponsor:
Protocol IDs: FCCC-86814, NCI-V87-0282

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 20 to 80
Sponsor:
Protocol IDs: MDA-DM-88027, NCI-V88-0440

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: MSKCC-92050, NCI-V92-0124

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-PROST, EU-90038

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 80
Sponsor: Other
Protocol IDs: CDR0000270970, FRE-FNCLCC-GETUG-12/0203, EU-20238, NCT00055731

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000353209, CALGB-90202, ECOG-CALGB-90202, SWOG-CALGB-90202, CAN-NCIC-PRC2, NCT00079001

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 40 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OL-007, NCT00076531

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CRO-04-62, NCT00128531

14.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: TROG 03.04, ACTRN12607000097448, NCT00193856

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: No age specified
Sponsor: Other
Protocol IDs: 05-8-4, NCT00243646

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0521, CDR0000462375, NCI-2009-00728, NCT00288080

17.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS21, NCT00295750

18.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0518, CDR0000476469, NCI-2009-00884, 0518, NCT00329797

19.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: XRP6976J_3501, EudraCT # : 2004-002203-32, UCLA-0511090-01, SANOFI-XRP6976J/3501, NCT00283062

20.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 79
Sponsor: Pharmaceutical / Industry
Protocol IDs: EGD-EC-003, 2005-004094-25, NCT00378690

21.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 38
Sponsor: Other
Protocol IDs: 2006603-01H, NCT00380406

22.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SA-CMX-01, NCT00426777

23.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 45 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OL-01110, NCT00598312

24.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: L-PC07-169, NCT00626431

25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS37, RISPSA, NCT00928434
1    
New Search